Slate Path Capital’s Atara Biotherapeutics ATRA Stock Holding History

Slate Path Capital’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell
2020 Q2	$6.12M	Hold
2020 Q1	$3.57M	Buy
2017 Q1	–	Sell
2016 Q4	$6.75M	Hold
2016 Q3	$10.2M	Buy
2016 Q2	$9.45M	Buy